Putnam Investments’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$653K Sell
29,127
-915
-3% -$18.9K ﹤0.01% 899
2023
Q3
$607K Sell
30,042
-259
-0.9% -$5.87K ﹤0.01% 895
2023
Q2
$774K Sell
30,301
-948
-3% -$25K ﹤0.01% 872
2023
Q1
$929K Sell
31,249
-1,324
-4% -$38.4K ﹤0.01% 862
2022
Q4
$881K Sell
32,573
-17
-0.1% -$416 ﹤0.01% 853
2022
Q3
$710K Sell
32,590
-587
-2% -$15.3K ﹤0.01% 893
2022
Q2
$907K Buy
33,177
+17,756
+115% +$510K ﹤0.01% 877
2022
Q1
$517K Sell
15,421
-1,099
-7% -$35.4K ﹤0.01% 989
2021
Q4
$573K Buy
+16,520
New +$534K ﹤0.01% 933
2017
Q2
Sell
-30,737
Closed -$1.17M 1121
2017
Q1
$1.17M Sell
30,737
-3,219
-9% -$125K ﹤0.01% 970
2016
Q4
$1.26M Sell
33,956
-322
-0.9% -$11.5K ﹤0.01% 952
2016
Q3
$1.19M Sell
34,278
-72,446
-68% -$2.54M ﹤0.01% 981
2016
Q2
$3.47M Buy
+106,724
New +$3.27M 0.01% 779
2015
Q2
Sell
-5,811
Closed -$286K 1494
2015
Q1
$286K Buy
5,811
+200
+4% +$9.27K ﹤0.01% 1415
2014
Q4
$255K Buy
+5,611
New +$220K ﹤0.01% 1410

Other funds holding AVNS

Putnam Investments's AVNS Position: Q4 2023 in Review

Putnam Investments reduced its Avanos Medical (AVNS) stake by 3% in Q4 2023, selling an estimated $18.9K and leaving 29,127 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

Putnam Investments first reported a position in AVNS in Q4 2014 and has held it in 15 quarters since. The position peaked at $3.47M in Q2 2016. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.

  • Putnam Investments held 29,127 shares of Avanos Medical worth $653K as of Q4 2023.
  • Putnam Investments sold 915 Avanos Medical shares in Q4 2023, an estimated $18.9K.
  • Avanos Medical made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #899 holding.
  • Putnam Investments first reported a position in Avanos Medical in Q4 2014 and has held it in 15 quarters since.
  • Putnam Investments's Avanos Medical position peaked at $3.47M in Q2 2016.
  • 265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.